ASCO 2018 (Brahmer) immune-related hepatitis grade from caller AST, ALT, and total bili…
ASCO 2018 (Brahmer) immune-related hepatitis grade from caller AST, ALT, and total bilirubin as folds of laboratory ULN (mg/dL only). Lab grade is the max of transaminase and bilirubin Table 2.2 bands; decompensated liver upgrades to grade 4; symptomatic comp…
by api.magentlab.com · discovered, not yet claimed by its owner · updated 2026-10-13
Mirrored from Coinbase's public x402 Bazaar. The description is the provider's own text and has not been reviewed here; the payment requirements are copied as published.
What it does
ASCO 2018 (Brahmer) immune-related hepatitis grade from caller AST, ALT, and total bilirubin as folds of laboratory ULN (mg/dL only). Lab grade is the max of transaminase and bilirubin Table 2.2 bands; decompensated liver upgrades to grade 4; symptomatic compensated liver dysfunction upgrades to grade 3. ICI action: continue (0-1), hold (2), or permanently discontinue (3-4). Not a medical device, not a diagnosis, not DILI/RUCAM, not R factor, not a steroid dose; magent does not assay enzymes.
Tags: irae-hepatitis · liver · checkpoint · asco · calculator · bazaar
Call contract
- Method
- POST
- Input
- HTTP request
- Output
- json
- Last paid call
- 2026-10-13
{
"items": [
{
"alt_u_l": 50,
"alt_uln_u_l": 40,
"ast_u_l": 80,
"ast_uln_u_l": 40,
"bilirubin_mg_dl": 1,
"bilirubin_uln_mg_dl": 1,
"decompensated_liver": false,
"symptomatic_liver_dysfunction": false
},
{
"alt_u_l": 50,
"alt_uln_u_l": 40,
"ast_u_l": 80,
"ast_uln_u_l": 40,
"bilirubin_mg_dl": 1,
"bilirubin_uln_mg_dl": 1,
"decompensated_liver": false,
"symptomatic_liver_dysfunction": false
}
]
}{
"count": 2,
"items": [
{
"alt_u_l": 50,
"alt_uln_u_l": 40,
"ast_u_l": 80,
"ast_uln_u_l": 40,
"bilirubin_mg_dl": 1,
"bilirubin_ratio": 1,
"bilirubin_uln_mg_dl": 1,
"citation": {
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA",
"doi": "10.1200/JCO.2017.77.6385",
"id": "brahmer-2018",
"pmid": "29442540",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline"
},
"criteria": [
{
"factor": "decompensated_liver",
"met": false
},
{
"factor": "symptomatic_liver_dysfunction",
"met": false
}
],
"decompensated_liver": false,
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula": "irae_hepatitis",
"formula_expression": "lab_grade = max(transaminase_grade(max(AST/AST_ULN, ALT/ALT_ULN)), bilirubin_grade(TBili/TBili_ULN)); first-match: decompensated_liver -> max(lab_grade, 4); else symptomatic_liver_dysfunction -> max(lab_grade, 3); else lab_grade. Transaminase: <1x -> 0, ULN-3x -> 1, >3-5x -> 2, >5-20x -> 3, >20x -> 4. Bilirubin: <1x -> 0, ULN-1.5x -> 1, >1.5-3x -> 2, >3-10x -> 3, >10x -> 4 (Brahmer 2018 Table 2.2). icpi_action: 0-1 continue, 2 hold, 3-4 permanently_discontinue. mg/dL bilirubin only. Not DILI/RUCAM. Not R factor. magent does not assay enzymes. Not a diagnosis. Not a steroid dose",
"grade": 1,
"icpi_action": "continue",
"symptomatic_liver_dysfunction": false,
"transaminase_ratio": 2
},
{
"alt_u_l": 50,
"alt_uln_u_l": 40,
"ast_u_l": 80,
"ast_uln_u_l": 40,
"bilirubin_mg_dl": 1,
"bilirubin_ratio": 1,
"bilirubin_uln_mg_dl": 1,
"citation": {
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA",
"doi": "10.1200/JCO.2017.77.6385",
"id": "brahmer-2018",
"pmid": "29442540",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline"
},
"criteria": [
{
"factor": "decompensated_liver",
"met": false
},
{
"factor": "symptomatic_liver_dysfunction",
"met": false
}
],
"decompensated_liver": false,
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula": "irae_hepatitis",
"formula_expression": "lab_grade = max(transaminase_grade(max(AST/AST_ULN, ALT/ALT_ULN)), bilirubin_grade(TBili/TBili_ULN)); first-match: decompensated_liver -> max(lab_grade, 4); else symptomatic_liver_dysfunction -> max(lab_grade, 3); else lab_grade. Transaminase: <1x -> 0, ULN-3x -> 1, >3-5x -> 2, >5-20x -> 3, >20x -> 4. Bilirubin: <1x -> 0, ULN-1.5x -> 1, >1.5-3x -> 2, >3-10x -> 3, >10x -> 4 (Brahmer 2018 Table 2.2). icpi_action: 0-1 continue, 2 hold, 3-4 permanently_discontinue. mg/dL bilirubin only. Not DILI/RUCAM. Not R factor. magent does not assay enzymes. Not a diagnosis. Not a steroid dose",
"grade": 1,
"icpi_action": "continue",
"symptomatic_liver_dysfunction": false,
"transaminase_ratio": 2
}
],
"path": "/api/calc/irae_hepatitis"
}Use with an agent
- Discover. Agents find this listing with
GET https://bazaar.saylorinnovations.com/discovery/search?query=…, the MCP toolsearch_resources, or/discovery/resources. - Inspect. Fetch
/resources/39075.jsonfor the price and payment options. - Pay. Call
GET https://api.magentlab.com/api/calc/irae_hepatitis. The provider answers402with its payment requirements. An x402 client signs one of the options below and retries withPAYMENT-SIGNATURE. - Execute. The provider returns
200with the data. Agent Bazaar is not in the request path and never sees your payment.
For humans
You don't need an account or an API key; you need a wallet holding a small amount of USDC on Base, and an x402-capable client (see the examples below). Call the endpoint unpaid first to see exactly what it asks for.
Pricing & payment
- Price
- $0.005 / request
- Protocol
- x402 v2
- Auth
- No account or API key. Pay per request.
- Networks
- Base
- Demand
- 5 calls · 2 unique payers in 30d (public x402 Bazaar data)
x402 payment requirements
| Scheme | Network | Asset | Amount | Pay to | Timeout |
|---|---|---|---|---|---|
| exact | Base eip155:8453 | USDC | $0.005 | 0x836Be278f1739fB4308091cD1852F7971Bc19Ee2 | 600s |
accepts[] (raw JSON)
[
{
"scheme": "exact",
"network": "eip155:8453",
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"amount": "5000",
"amountUsd": 0.005,
"maxTimeoutSeconds": 600
}
]Schemas
Output schema (JSON Schema)
{
"properties": {
"example": {
"type": "object"
},
"type": {
"type": "string"
}
},
"required": [
"type"
],
"type": "object"
}Example shape — generated from the schema, not a captured live response
{
"example": {},
"type": "string"
}Examples
curl "https://api.magentlab.com/api/calc/irae_hepatitis"
# -> 402 Payment Required, accepts[] lists how to pay
# retry with a PAYMENT-SIGNATURE (or PAYMENT header) once paidconst res = await fetch("https://api.magentlab.com/api/calc/irae_hepatitis");
if (res.status === 402) {
const { accepts } = await res.json();
// pay one of accepts[] via an x402 client, then retry with the payment header
}import httpx
res = httpx.get("https://api.magentlab.com/api/calc/irae_hepatitis")
if res.status_code == 402:
accepts = res.json()["accepts"]
# pay one of accepts[] via an x402 client, then retry with the payment headerDetails
- Provider
- api.magentlab.com
- Endpoint
- https://api.magentlab.com/api/calc/irae_hepatitis
- Machine-readable
/resources/39075.json